Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.
about
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeEvaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in JapanIn vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.Gemifloxacin: a new fluoroquinolone.Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000.Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniaeFluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae.Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.Levofloxacin-resistant Streptococcus pneumoniae: second look.Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.Quinolone resistance among pneumococci: therapeutic and diagnostic implications.Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.
P2860
Q33983643-C67E4BB6-5959-4FBD-8DF9-D5111CCBCE9BQ34108423-E6EC11A1-ED94-4EC2-8ABF-E1FCEF71301AQ34139244-02708389-5294-42DC-9BA8-B4D5DD67C9C0Q34144100-23C9B900-8E7F-46BB-81B2-510E99DEF1D7Q34230118-A04DA054-2206-4A33-8A16-599D42441E01Q34352053-5C7BEE48-9D73-4D77-8230-A852B2A4CD49Q34502866-2D6060D3-1120-4354-8D39-297B8D476425Q35798789-056EFE18-A03C-4B10-A048-AE13C389781AQ36880109-0C528CEA-4D22-430F-8710-A0629501526EQ37703568-449EF64E-335C-46EF-8D84-A0D21D0FFD8FQ37733449-CAFB61BC-43C5-4D4C-8C28-6B8CB645FB00Q37867123-5A5304F2-AF8D-4549-8CF3-9E72D4284E00Q39651028-19659F2D-1DD3-491E-9C25-53B20F5B6A99Q39652363-266D56F7-E051-4651-A1EB-F34396F0AF39Q39682438-E057D58C-49FB-4BD1-A1A0-0FB75FB248E4Q39743304-12209251-B104-4392-9CEC-1A160E1622F1Q39792565-46A27290-0DC6-40ED-8887-69ADF95AFDA0Q42730587-6C1E5C42-999B-411F-BA2F-AFAB29ED76FFQ42844652-6E6B17BA-87F6-4A83-967E-DE9FF32BBF1BQ44883946-295E3983-7907-412D-9C71-1F497CCEBEFCQ45299954-D9FE0929-6E54-4BA9-9EFA-1D9324E06BFF
P2860
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@ast
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@en
type
label
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@ast
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@en
prefLabel
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@ast
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@en
P2093
P2860
P1476
Activities of clinafloxacin, g ...... tant Streptococcus pneumoniae.
@en
P2093
C G Whitney
F C Tenover
J H Jorgensen
J M Swenson
L M Weigel
M J Ferraro
P2860
P304
P356
10.1128/AAC.44.11.2962-2968.2000
P407
P577
2000-11-01T00:00:00Z